During the past decade, Women's Health Specialty Care conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 7 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Women's Health Specialty Care" #1 sponsor was "Allergan" with 4 trials, followed by "GTx" with 3 trials sponsored, "Pfizer" with 2 trials sponsored, "Ipsen" with 1 trials sponsored and "Solace Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Women's Health Specialty Care" #1 collaborator was "TARIS Biomedical, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Women's Health Specialty Care" are "Stress Urinary Incontinence" (4 trials), "Cystitis, Interstitial" (3 trials), "Overactive Bladder" (3 trials), "Urinary Incontinence" (2 trials) and "Interstitial Cystitis" (1 trials). Many other conditions were trialed in "Women's Health Specialty Care" in a lesser frequency.

Most popular intervention types in "Women's Health Specialty Care" are "Drug" (9 trials), "Other" (3 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "LiRIS Placebo" (3 trials), "GTx-024" (2 trials), "LiRIS®" (2 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Women's Health Specialty Care" are 7 trials for "Female" genders and 5 trials for "All" genders.

Currently, there are NaN active trials in "Women's Health Specialty Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Women's Health Specialty Care, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Women's Health Specialty Care, 0 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".